About The Second Hospital of Dalian Medical University
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
The Second Affiliated Hospital of Dalian Medical University
5
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
4
BeiGene
3
Chengdu Kanghong Biotech Co., Ltd.
2
Fudan University
2
Institute of Hematology & Blood Diseases Hospital
2
Takeda
2
Antengene Corporation
1
Beijing InnoCare Pharma Tech Co., Ltd.
1
Beijing Institute of Heart, Lung and Blood Vessel Diseases
1
Beijing Northland Biotech. Co., Ltd.
1
Clinical Trials at The Second Hospital of Dalian Medical University
During the past decade, The Second Hospital of Dalian Medical University conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 1 clinical trials were completed, i.e. on
average, 2.2% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 1 clinical trials were completed. i.e. 5.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
2012-03-01
2014-06-01
Completed
200
A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer
2013-07-01
2016-05-01
Terminated
27
Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)
2014-06-01
2018-08-31
Completed
556
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
2014-09-01
2016-12-01
Unknown status
1,600
To Compare the Incidence of POST Between a TaperGuard ETT and Cylindrical-shaped ETT Under High Cuff Pressure
2015-12-01
2016-02-01
Unknown status
40
Optimal TCI Regimen for Sedation of Elderly Undergoing Fiberoptic Bronchoscopy
2015-11-01
2016-04-01
Completed
70
Impact of Local Anesthesia on Postbronchoscopy Fever: a Randomised Controlled Study
2016-05-01
2016-11-01
Completed
160
A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI
2018-12-01
2020-01-01
Withdrawn
0
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Second Hospital of Dalian Medical University" #1 sponsor was "The Second Affiliated Hospital of Dalian Medical University" with 5 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 4 trials
sponsored, "BeiGene" with 3 trials sponsored, "Chengdu Kanghong Biotech Co., Ltd." with 2 trials sponsored and "Fudan University"
with 2 trials sponsored. Other sponsors include 28 different institutions and
companies that sponsored additional 36 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Hospital of Dalian Medical University"
#1 collaborator was "The Second Affiliated Hospital of Dalian Medical University" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Beijing Anzhen Hospital" with 1 trials as a collaborator, "Beijing Shijitan Hospital Affiliated to Capital Medical University" with 1 trials as a collaborator and "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 26 trials.
Clinical Trials Conditions at The Second Hospital of Dalian Medical University
According to Clinical.Site data, the most researched conditions in "The Second Hospital of Dalian Medical University" are
"Breast Cancer" (5 trials), "Hyperphosphatemia" (2 trials), "Macular Edema" (2 trials), "Postoperative Complications" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "The Second Hospital of Dalian Medical University" in a lesser frequency.
Clinical Trials Intervention Types at The Second Hospital of Dalian Medical University
Most popular intervention types in "The Second Hospital of Dalian Medical University" are "Drug" (38 trials), "Other" (7 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Anlotinib" (2 trials), "Carboplatin" (2 trials), "Cyclophosphamide" (2 trials), "Etoposide" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at The Second Hospital of Dalian Medical University
The vast majority of trials in "The Second Hospital of Dalian Medical University" are
43 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at The Second Hospital of Dalian Medical University
Currently, there are NaN active trials in "The Second Hospital of Dalian Medical University".
undefined are not yet recruiting,
17 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in The Second Hospital of Dalian Medical University,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in The Second Hospital of Dalian Medical University, 4 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 6 trials that are defined as “Not Applicable".